Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Boersma

Showing results (281-290 of 679) with videos related to

Pageof 68
Sort By:
The American Journal of Cardiology|March 31, 2009
Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study)Olaf Schouten, Jan-Peter van Kuijk, Willem-Jan Flu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 22, 2009
Factors affecting sensitivity and specificity of diagnostic testing: dobutamine stress echocardiographyMarcel L Geleijnse, Boudewijn J Krenning, Bas M van Dalen, et al.
Arquivos Brasileiros De Cardiologia|November 1, 2018
Adiponectin in Relation to Coronary Plaque Characteristics on Radiofrequency Intravascular Ultrasound and Cardiovascular OutcomeBárbara Campos Abreu Marino, Nermina Buljubasic, Martijn Akkerhuis, et al.
Circulation|February 16, 2006
Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapyGabe B Bleeker, Theodorus A M Kaandorp, Hildo J Lamb, et al.
Heart (British Cardiac Society)|September 25, 2017
Prognostic value of galectin-3 in adults with congenital heart diseaseVivan J M Baggen, Annemien E van den Bosch, Jannet A Eindhoven, et al.
Journal of the American Heart Association|March 28, 2018
Prognostic Value of Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in Adults With Congenital Heart DiseaseVivan J M Baggen, Sara J Baart, Annemien E van den Bosch, et al.
Circulation|September 6, 2007
Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baselineGabe B Bleeker, Sjoerd A Mollema, Eduard R Holman, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 18, 2016
Matrix metalloproteinases as candidate biomarkers in adults with congenital heart diseaseVivan J M Baggen, Jannet A Eindhoven, Annemien E van den Bosch, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 27, 2020
COvid MEdicaTion (COMET) study: protocol for a cohort studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
Heart (British Cardiac Society)|February 1, 2019
Prognostic value of soluble ST2 in adults with congenital heart diseaseLaurie W Geenen, Vivan J M Baggen, Annemien E van den Bosch, et al.
Pageof 68

Showing results (281-290 of 679) with videos related to

Sort By:
Pageof 68
The American Journal of Cardiology|March 31, 2009
Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study)Olaf Schouten, Jan-Peter van Kuijk, Willem-Jan Flu, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 22, 2009
Factors affecting sensitivity and specificity of diagnostic testing: dobutamine stress echocardiographyMarcel L Geleijnse, Boudewijn J Krenning, Bas M van Dalen, et al.
Arquivos Brasileiros De Cardiologia|November 1, 2018
Adiponectin in Relation to Coronary Plaque Characteristics on Radiofrequency Intravascular Ultrasound and Cardiovascular OutcomeBárbara Campos Abreu Marino, Nermina Buljubasic, Martijn Akkerhuis, et al.
Circulation|February 16, 2006
Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapyGabe B Bleeker, Theodorus A M Kaandorp, Hildo J Lamb, et al.
Heart (British Cardiac Society)|September 25, 2017
Prognostic value of galectin-3 in adults with congenital heart diseaseVivan J M Baggen, Annemien E van den Bosch, Jannet A Eindhoven, et al.
Journal of the American Heart Association|March 28, 2018
Prognostic Value of Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in Adults With Congenital Heart DiseaseVivan J M Baggen, Sara J Baart, Annemien E van den Bosch, et al.
Circulation|September 6, 2007
Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baselineGabe B Bleeker, Sjoerd A Mollema, Eduard R Holman, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 18, 2016
Matrix metalloproteinases as candidate biomarkers in adults with congenital heart diseaseVivan J M Baggen, Jannet A Eindhoven, Annemien E van den Bosch, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 27, 2020
COvid MEdicaTion (COMET) study: protocol for a cohort studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
Heart (British Cardiac Society)|February 1, 2019
Prognostic value of soluble ST2 in adults with congenital heart diseaseLaurie W Geenen, Vivan J M Baggen, Annemien E van den Bosch, et al.
Pageof 68